About Mednext Biotech Limited
Data last updated:
Mednext Biotech Limited is a public limited company based in Udaipur, Rajasthan, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 August 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24232RJ2012PLC039813. Its GSTIN is 08AAICM1251G2ZM (Rajasthan). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1 Cr. It was formerly known as Mednext Biotech Private Limited. It is led by directors including Neelam Vyas and Anil Kumar Vyas.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1st Floor 30 Mahaveer Nagar New Bhupalpura, Udaipur, Rajasthan, India – 313001.
As per the financials filed for FY 2025, the company reported a revenue of ₹36.86 Cr, a decline of 32% compared to the previous year. For the same year it recorded a net profit of ₹4.16 Cr (net margin 11.3%) and EBITDA of ₹7.2 Cr (EBITDA margin 19.5%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 22% over five years.
The company has about 33 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹16.59 Cr and satisfied charges of ₹10.01 Cr on record. Court records list 3 cases involving the company, including 3 filed by the company; 3 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mednextpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address1st Floor 30 Mahaveer Nagar New Bhupalpura, Udaipur, Rajasthan, India – 313001
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Mednext Biotech Limited
The main business activity of Mednext Biotech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Mednext Biotech Limited FY 2025 filings available
Mednext Biotech Limited reported revenue of ₹36.86 Cr (down 32% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Mednext Biotech Limited
Revenue fell 32% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 22%. EBITDA fell 44% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Mednext Biotech Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹7.2 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹4.16 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Mednext Biotech Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 19.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 11.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Mednext Biotech are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Mednext Biotech Limited
Mednext Biotech Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shifa Remedies Private Limited | ₹37.06 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | New Delhi, Delhi, India |
| Acies Pharmaceutical Private Limited | ₹37.03 Cr (FY 2025) | •••• | •••• | 68.0% | •••• | Dehradun, Uttarakhand, India |
| Nexus Pharma Chem Private Limited | ₹37.01 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Ahmedabad, Gujarat, India |
| Lexine Technochem Private Limited | ₹36.97 Cr (FY 2025) | •••• | •••• | 22.0% | •••• | Salvli, Gujarat, India |
| Prism Life Sciences Limited | ₹36.89 Cr (FY 2025) | •••• | •••• | -11.0% | •••• | Thane, Maharashtra, India |
| Mednext Biotech Limited this company | ₹36.86 Cr (FY 2025) | •••• | •••• | -32.0% | •••• | Udaipur, Rajasthan, India |
| Bharat Explosives Limited | ₹36.81 Cr (FY 2025) | •••• | •••• | -13.0% | •••• | Uttar Pradesh, India |
| Shukra Pharmaceuticals Limited Listed | ₹36.79 Cr (FY 2025) | •••• | •••• | -52.0% | •••• | Ahmedabad, Gujarat, India |
| Gitanjali Chemicals Private Limited | ₹36.72 Cr (FY 2024) | •••• | •••• | -21.0% | •••• | Mumbai, Maharashtra, India |
| Quality Bestochem Formulations Private Limited | ₹36.71 Cr (FY 2024) | •••• | •••• | 18.0% | •••• | Delhi, India |
| Anphar Organics Private Limited. | ₹36.7 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Jammu, Jammu and Kashmir, India |
Peers are the five companies nearest above and the five nearest below Mednext Biotech by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Mednext Biotech Limited
Mednext Biotech Limited is audited by BHUPENDRA S JAIN & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| BHUPENDRA S JAIN & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Mednext Biotech Limited
Mednext Biotech has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neelam Vyas Also directs: Mednext Pharma Private Limited, Alice Pharma Private Limited, Tirtham Hospitality Private Limited and 1 more | Director | 17 Aug 2012 | 14 Years 1 Months | Current |
| Anil Kumar Vyas Also directs: Mednext Pharma Private Limited, Ceza Formulations Private Limited, Alice Pharma Private Limited and 1 more | Director | 10 Oct 2017 | 8 Years 11 Months | Current |
| Shriansh Vyas | Director | 08 Feb 2025 | 1 Years 8 Months | Current |
Ownership and Shareholding of Mednext Biotech Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Mednext Biotech Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Mar 2022 | Others | ₹15.99 Cr | Open |
| 16 Mar 2022 | Others | ₹60 Lakh | Open |
| 20 Jul 2020 | Others | ₹65 Lakh | Satisfied |
| 01 Jun 2019 | Others | ₹5.61 Cr | Satisfied |
| 31 Mar 2018 | Others | ₹3.75 Cr | Satisfied |
Total charge records: 5 View all charges
Legal Cases of Mednext Biotech Limited
Mednext Biotech Limited has 3 court cases on record: 3 filed by Mednext Biotech. All cases are pending. Status as checked between 21 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 0 | 3 |
Cases on record (2 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Rajasthan | Interim or miscellaneous application | Filed by the company against Union of India | Pending |
| High Court of Rajasthan | Writ petition | Filed by the company against Union of India | Pending |
Full case history
All 3 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Mednext Biotech Limited
Mednext Biotech Limited has a workforce of 33 employees as of Apr 07, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Mednext Biotech Limited
Mednext Biotech has one previous CIN (Corporate Identification Number): U24232RJ2012PTC039813. The current CIN is U24232RJ2012PLC039813, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232RJ2012PLC039813 | Current |
| U24232RJ2012PTC039813 | Previous |
Recent Activity on Mednext Biotech Limited
Mednext Biotech Limited has 8 board changes on record since 2012: 6 appointments and 2 cessations. The latest: Shriansh Vyas was appointed as Director on 08 Feb 2025.
9 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Mednext Biotech Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Mednext Biotech Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Mednext Biotech Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Mednext Biotech Limited
Mednext Biotech has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAICM1251G2ZM | Rajasthan | Active | 05 Mar 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Mednext Biotech Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mednext Biotech Limited
Mednext Biotech is an active public limited company based in Udaipur, Rajasthan, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 August 2012 (14+ years old) and is registered under CIN U24232RJ2012PLC039813.
Mednext Biotech reported revenue of ₹36.86 Cr for FY 2025 (down 32% YoY).
Mednext Biotech has 3 current directors:
- Neelam Vyas - Director
- Anil Kumar Vyas - Director
- Shriansh Vyas - Director
Mednext Biotech reported a net profit of ₹4.16 Cr (net margin 11.3%) and EBITDA of ₹7.2 Cr (EBITDA margin 19.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Mednext Biotech is 7% over three years and 22% over five years. In the latest year (FY 2025) revenue fell 32%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Mednext Biotech is 08AAICM1251G2ZM, registered in Rajasthan. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Mednext Biotech is U24232RJ2012PLC039813. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mednext Biotech has 3 court cases on record: 3 filed by the company. 3 are pending.
Mednext Biotech was incorporated on 17 August 2012, making it 14+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Mednext Biotech by revenue are Shifa Remedies Private Limited, Acies Pharmaceutical Private Limited, Nexus Pharma Chem Private Limited, Lexine Technochem Private Limited, Prism Life Sciences Limited and 5 more, all in the Pharma industry (Formulations).
Shriansh Vyas was appointed as Director on 08 Feb 2025. Sunil Chittora ceased to be Director on 07 Oct 2023. Pankaj Vyas was appointed as Director on 06 Oct 2023. Mednext Biotech has 8 board changes on record in total.